THE BALANCE

Private admissions

Let’s talk about your next step.

Speak with our admissions team about treatment for you or someone you care about.

Your admissions team

Jil Moore
Jil MooreClient Relations Director
Cynthia Nakhle
Cynthia NakhleAdmissions Manager
Abdullah Boulad, Founder & CEO

Prefer to speak with our founder?

Abdullah Boulad · Founder & CEO

Clinical resource

Opioids Strongest to Weakest: Understanding Potency and Risk

Opioid potency is not a simple safety ranking. Understand why dose, route, formulation, tolerance and other medicines matter, and why a conversion chart must not be used to switch opioids yourself.

Medically reviewed byDr. Sarah Boss, MD
Stone residence with a swimming pool, lawn and palm trees

Quick Summary

  • Opioid potency is not a universal safety ranking: dose, route, formulation and individual factors matter. Do not use a potency list or morphine-equivalent chart to change or replace an opioid yourself. Suspected overdose requires emergency help; continuing treatment should be based on an individual clinical assessment.

A list of opioids from strongest to weakest cannot tell you which medicine is safe for you or how to replace one with another. Potency depends on the effect being compared, the dose, the route and the formulation; overdose risk also depends on the person and other substances involved. Never use a ranking or conversion chart to change your own opioid dose. If someone is unresponsive or breathing slowly after possible opioid use, call emergency services immediately and give naloxone if available, following its instructions and the dispatcher’s guidance.

What does opioid potency mean?

In pharmacology, potency describes how much of a substance is needed to produce a specified effect under specified conditions. It does not mean that a medicine is better for every patient, that it produces the best pain relief in every situation, or that it carries a fixed level of danger regardless of dose. Comparing one milligram of two medicines without considering their formulations and routes can therefore be misleading.

Opioids include naturally derived, semisynthetic and synthetic substances that act on opioid receptors. Some have established medical uses, while products obtained outside regulated supply can have an uncertain composition. The World Health Organization’s opioid overview explains both clinical uses and overdose risks. A substance’s name alone does not reveal what is in an unregulated product or what effect it will have.

Why there is no universally correct strongest-to-weakest list

A valid comparison must state what is being measured. Pain relief, speed of onset, duration and effects on breathing are not interchangeable measures. A product taken by mouth cannot simply be compared with a patch or injection as though all deliver the medicine in the same way. Even a carefully constructed clinical estimate cannot capture every individual response.

The CDC’s 2022 opioid prescribing guideline warns that equianalgesic conversions are estimates and do not account fully for individual variation. Its morphine milligram equivalent calculations must not be used to determine a replacement dose when switching opioids. A person’s response to one opioid does not establish complete tolerance to another. This is a clinical decision, not a calculation for self-treatment.

Fentanyl and carfentanil: why extreme potency is not a treatment guide

Fentanyl is a highly potent synthetic opioid with specific medical uses and significant risks. Illicitly manufactured fentanyl and related substances, including carfentanil, have been associated with fatal overdoses. These facts do not make an internet potency ranking a useful way to choose a pain treatment. Nor can the concentration of an unregulated mixture be established from its appearance or a seller’s description.

It is not necessary to know which opioid is the most potent before responding to suspected overdose. Difficulty breathing and reduced responsiveness require immediate action. Likewise, do not assume a tablet is a verified prescription medicine because its color or markings look familiar. The key issue is a reliable medicine supply and an individually appropriate prescription, not which name appears at the top of a list.

Morphine, hydromorphone, oxycodone and oxymorphone

These names commonly appear in comparisons of opioid pain medicines. They are not interchangeable on a milligram-for-milligram basis. Product strength, immediate- or extended-release formulation, route and the person’s previous treatment must be considered. A lower number on the label can still represent a substantial clinical effect; a larger number does not necessarily mean a stronger or more suitable treatment.

When a prescription changes, ask which product is being stopped, which is being started and what to do with remaining supplies. Do not combine the old and new medicines unless that is explicitly part of the prescribing plan. The pharmacist can clarify the label and formulation. A chart found online should not override the instructions from the clinician who has assessed the actual treatment history.

Methadone and buprenorphine require their own context

Methadone and buprenorphine are used in evidence-based treatment for opioid use disorder, as well as having pain-treatment applications in appropriate formulations. Their roles cannot be summarized by placing them between two other drugs in a strength list. They have different pharmacological properties and require a suitable prescribing and monitoring plan. Their use in treatment is not a reason to take them without medical supervision.

The CDC advises particular caution with methadone conversions because its duration and breathing effects can be difficult to predict from pain relief alone. Buprenorphine is a partial opioid agonist and is not included in the guideline’s standard pain-medicine conversion table. These distinctions support individualized treatment; they do not provide a basis for calculating your own starting or replacement dose.

Codeine, tramadol and meperidine are not risk-free alternatives

The label “weak opioid” can create false reassurance. Codeine and tramadol can still cause serious harm, including breathing problems, and other effects or interactions may matter in an individual case. Meperidine, also called pethidine, has its own precautions and should not be selected because an online list places it below another drug. Lower comparative potency does not remove the need for an appropriate prescription.

The MedlinePlus tramadol guide describes important warnings, interactions and the need to follow the prescribed regimen. Combination products also contain other ingredients whose risks are not captured by an opioid ranking. Read the complete medicine label rather than focusing only on the opioid name, and ask a pharmacist before adding an over-the-counter product.

Heroin and other unregulated products cannot be ranked reliably

An unregulated product may contain substances other than those expected, and its composition can vary. A potency comparison for a known substance does not establish the contents or safety of a particular packet or tablet. It is therefore misleading to present a fixed ranking as though the same amount would have the same effect on different occasions.

Someone seeking help does not need to identify every ingredient before contacting a service. Explain what is known and what is uncertain. If an overdose is suspected, the immediate response should not wait for testing or a precise drug name. Longer-term support can address the pattern of use, medical needs and practical barriers without treating the person as a stereotype.

Alcohol, sedatives and tolerance can change the risk

Taking opioids with alcohol, benzodiazepines or other sedating substances can increase the danger of impaired breathing. A familiar dose is not automatically safe when another substance has been added. The National Institute on Drug Abuse explains the risks of combining benzodiazepines and opioids. Tell the prescribing team about all medicines and substances, including those used only occasionally.

Tolerance may decrease after a period without opioids, making a return to a previously used amount especially dangerous. Do not use past experience as proof of current safety. Equally, do not abruptly stop a long-term prescribed treatment on your own because a strength list has frightened you. Ask the clinician for a review of benefits, risks and any appropriate changes.

Does briefly touching fentanyl cause an overdose?

The claim that briefly touching or merely being near a substance necessarily causes an opioid overdose is misleading. CDC/NIOSH guidance states that brief skin contact with illicit fentanyl is not expected to cause toxic effects when visible contamination is promptly removed. Inhaled powder, contact with the eyes or mouth, ingestion, needlestick exposure and certain prolonged exposures are different situations.

Do not handle or disturb an unknown powder to identify it. Follow local emergency guidance. If skin is contaminated, NIOSH recommends soap and water rather than alcohol hand rub or bleach. Correcting exaggerated incidental-contact claims does not mean unknown drugs are safe; it means explaining the relevant exposure route accurately and avoiding unnecessary panic.

Recognizing overdose and seeking treatment

Unresponsiveness, very slow or absent normal breathing and other signs of opioid poisoning require emergency help. Call 911 in the United States, 999 in the United Kingdom or 112 in the European Union. Use naloxone if available according to its instructions, follow the dispatcher’s guidance on breathing support and stay until help arrives when it is safe. Improvement after naloxone does not remove the need for medical assessment.

For continuing difficulties, opioid use disorder treatment should be based on an individual assessment. CDC guidance recommends medication treatment and advises against detoxification alone. Information about assessment and treatment planning can help clarify options after immediate safety needs have been addressed.

Questions

Frequently Asked Questions

What is the strongest opioid?
There is no single clinical ranking that applies across all doses, routes, formulations and effects. Highly potent substances such as fentanyl and carfentanil pose serious risks, but a ranking does not identify the safest medicine or a safe amount for an individual.
Can I use a morphine-equivalent chart to switch medicines?
No. CDC guidance says not to use calculated morphine milligram equivalents to determine a replacement opioid dose. Switching requires clinical judgment about incomplete cross-tolerance, formulation and the individual’s health.
Is a weaker opioid always safer?
No. Dose, interactions, formulation, tolerance and individual health affect risk. Codeine and tramadol can still cause serious harm. Do not increase a dose or change treatment based on a strongest-to-weakest list.
Can brief skin contact with fentanyl cause poisoning?
CDC/NIOSH says brief contact is not expected to cause toxic effects when visible contamination is promptly removed. Other routes, such as inhaling powder or getting it in the eyes or mouth, carry different risks. Avoid handling unknown substances and follow emergency guidance.
What this includes
01

Clinical context

Clear information is framed around complex and co-occurring presentations.

02

Individual factors

Assessment remains essential because needs and risks differ from person to person.

03

Next steps

A confidential conversation can help clarify the most appropriate route forward.

Not sure where the situation fits?

Your admissions team

Jil Moore
Jil MooreClient Relations Director
Cynthia Nakhle
Cynthia NakhleAdmissions Manager

A confidential first conversation can help clarify the presentation and whether our setting is appropriate.

THE BALANCE
A PLACE TO BEGIN

Ask about our care